|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1997-3-11
|
|
pubmed:abstractText |
There are only limited data on bone mineral density (BMD) in adult patients with 21-hydroxylase deficiency (21-OHD). We have defined the effects of different glucocorticoid substitution therapies on BMD and body composition in these patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0300-0664
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
707-13
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9039336-Adolescent,
pubmed-meshheading:9039336-Adrenal Hyperplasia, Congenital,
pubmed-meshheading:9039336-Adult,
pubmed-meshheading:9039336-Body Mass Index,
pubmed-meshheading:9039336-Bone Density,
pubmed-meshheading:9039336-Cross-Sectional Studies,
pubmed-meshheading:9039336-Dexamethasone,
pubmed-meshheading:9039336-Dose-Response Relationship, Drug,
pubmed-meshheading:9039336-Female,
pubmed-meshheading:9039336-Glucocorticoids,
pubmed-meshheading:9039336-Humans,
pubmed-meshheading:9039336-Hydrocortisone,
pubmed-meshheading:9039336-Male,
pubmed-meshheading:9039336-Middle Aged,
pubmed-meshheading:9039336-Prednisolone,
pubmed-meshheading:9039336-Prednisone
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency.
|
|
pubmed:affiliation |
Department of Paediatrics, Kuopio University Hospital, Finland.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
